News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current FDMT market cap is 1.23B. The company's latest EPS is USD -2.0257 and P/E is -12.23.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 500k | 1.25M | 298k | 240k | 20.2M |
| Operating Income | -26.49M | -28.72M | -30.11M | -32.14M | -13.97M |
| Net Income | -25.69M | -27.38M | -28.68M | -29.62M | -10.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.99M | 13.61M | 18.04M | 3.13M | 20.72M |
| Operating Income | -50.76M | -56.66M | -71.33M | -110.03M | -112.87M |
| Net Income | -49.31M | -56.69M | -71.32M | -107.49M | -100.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 280.16M | 261.85M | 244.02M | 352.5M | 361.61M |
| Total Liabilities | 28.72M | 30.51M | 25.42M | 27.36M | 31.68M |
| Total Equity | 251.44M | 231.34M | 218.61M | 325.14M | 329.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 58.23M | 288.33M | 353.49M | 261.85M | 339.89M |
| Total Liabilities | 131.2M | 31.94M | 34.38M | 30.51M | 32.06M |
| Total Equity | -72.97M | 256.39M | 319.11M | 231.34M | 307.83M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -64.47M | -86.69M | -27.91M | -49.97M | -51.14M |
| Investing | 18.73M | -17.05M | 43.13M | 92.42M | 122.4M |
| Financing | 1.04M | 3.09M | 10.99M | 141.51M | 152.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.71M | -50.91M | -69.13M | -86.69M | -75.79M |
| Investing | -3.2M | -1M | -172.68M | -17.05M | 115.72M |
| Financing | -2.2M | 278.98M | 118.09M | 3.09M | 156.83M |
| Market Cap | 1.23B |
| Price to Earnings Ratio | -12.23 |
| Price to Sales Ratio | 59.52 |
| Price to Cash Ratio | 4.95 |
| Price to Book Ratio | 4.01 |
| Dividend Yield | - |
| Shares Outstanding | 49.78M |
| Average Volume (1 week) | 485.1k |
| Average Volume (1 Month) | 677.04k |
| 52 Week Change | 43.74% |
| 52 Week High | 36.25 |
| 52 Week Low | 9.44 |
| Spread (Intraday) | 10.16 (34.96%) |
| Company Name | 4D Molecular Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.4dmoleculartherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
